← Leaderboards
Jiang Zhu
Scripps Research Institute, The
$14,887,050
Attributed
$14,887,050
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.2M · FY2015–25$2.5M$1.9M$1.3M$625K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,887,050 · 8
By mechanism
R01$8,085,137 · 2
P01$4,180,555 · 3
U19$1,496,135 · 1
R56$600,348 · 1
R21$524,875 · 1
Top collaborators
No co-investigators on record.
Most similar at Scripps Research Institute, The
Same institution · by research overlap
- Mansun Law$19,290,800
- Christopher Yeh Chen$2,925,040
- Robyn L Stanfield$2,554,231
- Ian A Wilson$64,513,205
- Kelly Keisen Lee$10,991,280
Others in their field
Top investigators on “Vaccine Development”
- Lawrence Corey · Fred Hutchinson Cancer Center$718,120,301
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$554,939,981
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$394,383,754
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$392,263,550
- Dennis R. Burton · Scripps Research Institute$312,611,400
Research focus
Vaccine DevelopmentVaccine DesignAntibodiesEpitopesVaccinesImmunizationStructureAntigensNeutralizing AntibodyDesignNext Generation SequencingGlycoproteinsB-LymphocytesB Cell RepertoireResponseNonhuman PrimateVaccine CandidateHiv-1ImmunogenicityVirusEngineeringReportingBaseNanoparticle
Grant awards (27)
Novel HCV vaccine antigens and nanoparticles$590,566
P01 · FY2025 · AI · contact PI
Novel HCV vaccine antigens and nanoparticles$580,938
P01 · FY2024 · AI · contact PI
Uncleaved prefusion-optimized trimers on nanoparticles as HIV vaccines$969,072
R01 · FY2023 · AI · contact PI
Novel HCV vaccine antigens and nanoparticles$569,704
P01 · FY2023 · AI · contact PI
Uncleaved prefusion-optimized trimers on nanoparticles as HIV vaccines$969,072
R01 · FY2022 · AI · contact PI
Novel HCV vaccine antigens and nanoparticles$580,936
P01 · FY2022 · AI · contact PI
Uncleaved prefusion-optimized trimers on nanoparticles as HIV vaccines$969,072
R01 · FY2021 · AI · contact PI
Rational design and B cell responses of HIV epitope vaccines$638,644
R01 · FY2021 · AI · contact PI
Uncleaved prefusion-optimized trimers on nanoparticles as HIV vaccines$969,072
R01 · FY2020 · AI · contact PI
Rational design and B cell responses of HIV epitope vaccines$638,644
R01 · FY2020 · AI · contact PI
Env-Specific B Cell Repertoire Responses to NFL Trimer vaccines$292,223
P01 · FY2020 · AI · contact PI
Novel HCV vaccine antigens targeting conserved neutralizing epitopes$256,885
U19 · FY2020 · AI · contact PI
Uncleaved prefusion-optimized trimers on nanoparticles as HIV vaccines$992,504
R01 · FY2019 · AI · contact PI
Rational design and B cell responses of HIV epitope vaccines$638,644
R01 · FY2019 · AI · contact PI
Novel HCV vaccine antigens targeting conserved neutralizing epitopes$313,675
U19 · FY2019 · AI · contact PI
Env-Specific B Cell Repertoire Responses to NFL Trimer vaccines$280,575
P01 · FY2019 · AI · contact PI
Rational design and B cell responses of HIV epitope vaccines$638,644
R01 · FY2018 · AI · contact PI
Env-Specific B Cell Repertoire Responses to NFL Trimer vaccines$353,937
P01 · FY2018 · AI · contact PI
Novel HCV vaccine antigens targeting conserved neutralizing epitopes$316,208
U19 · FY2018 · AI · contact PI
Rational design and B cell responses of HIV epitope vaccines$661,769
R01 · FY2017 · AI · contact PI
Env-Specific B Cell Repertoire Responses to NFL Trimer vaccines$378,447
P01 · FY2017 · AI · contact PI
Novel HCV vaccine antigens targeting conserved neutralizing epitopes$319,627
U19 · FY2017 · AI · contact PI
Novel trimer platform on particles as HIV vaccine candidates$600,348
R56 · FY2016 · AI · contact PI
Env-Specific B Cell Repertoire Responses to NFL Trimer vaccines$553,229
P01 · FY2016 · AI · contact PI
Novel HCV vaccine antigens targeting conserved neutralizing epitopes$289,740
U19 · FY2016 · AI · contact PI
Structure-based immunogen design for hepatitis C virus$240,625
R21 · FY2016 · AI · contact PI
Structure-based immunogen design for hepatitis C virus$284,250
R21 · FY2015 · AI · contact PI